Human Phenotype Ontology 
Grandparent Node:
expand
Localized skin lesion (HP:0011355)help
Parent Node:
expand
Abnormal eyelid morphology (HP:0000492)help
Parent Node:
expand
Skin nodule (HP:0200036)help
..Starting node
..expand
Nodular changes affecting the eyelids (HP:0010732)help
Term ID: 10732
Name: Nodular changes affecting the eyelids
Synonym: Eyelid nodules
Definition: Nodular changes affecting the eyelids may have many different causes such as cystic lesions (chalaziae, hordeolae), lipogranulomas, melanomas, infectious diseases (Molluscum contagiosum) and many more.
Comments:
Reference: HP:0010732
Genes and Diseases:
 
       Child Nodes:
........expandXanthelasma (HP:0001114) help
........expandCyst of the eyelid (HP:0010604) help
................... HP:0010605 Chalazion
........expandHordeolum (HP:0010606) help
................... HP:0010607 Hordeolum externum
................... HP:0010608 Hordeolum internum

 Sister Nodes: 
..expandAcrokeratosis (HP:0200016) help
..expandHyperpigmented nodule (HP:0025529) help
..expandOsteoma cutis (HP:0025027) help
..expandSubcutaneous nodule (HP:0001482) help
..expandUmbilicated nodule (HP:0025103) help
..expandYellow nodule (HP:0025554) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010732HP:0010732Nodular changes affecting the eyelids0ABCA1 CL E G H1929ORPHA:425Apolipoprotein A-I deficiency191
HP:0010732HP:0010732Nodular changes affecting the eyelids0ABCG8 CL E G H6424113887OMIM:210250Sitosterolemia 176
HP:0010732HP:0010732Nodular changes affecting the eyelids0APOA1 CL E G H335600ORPHA:425Apolipoprotein A-I deficiency40
HP:0010732HP:0010732Nodular changes affecting the eyelids0APOA2 CL E G H336601OMIM:143890Hypercholesterolemia, familial, 19
HP:0010732HP:0010732Nodular changes affecting the eyelids0APOB CL E G H338603OMIM:144010Hypercholesterolemia, familial, 2356
HP:0010732HP:0010732Nodular changes affecting the eyelids0APOE CL E G H348613ORPHA:412Dysbetalipoproteinemia39
HP:0010732HP:0010732Nodular changes affecting the eyelids0CYP27A1 CL E G H15932605OMIM:213700Cerebrotendinous xanthomatosis114
HP:0010732HP:0010732Nodular changes affecting the eyelids0EPHX2 CL E G H20533402OMIM:143890Hypercholesterolemia, familial, 11
HP:0010732HP:0010732Nodular changes affecting the eyelids0G6PC1 CL E G H25384056OMIM:232200Glycogen storage disease ia
HP:0010732HP:0010732Nodular changes affecting the eyelids0GHR CL E G H26904263OMIM:143890Hypercholesterolemia, familial, 198
HP:0010732HP:0010732Nodular changes affecting the eyelids0LDLR CL E G H39496547OMIM:143890Hypercholesterolemia, familial, 12157
HP:0010732HP:0010732Nodular changes affecting the eyelids0LPL CL E G H40236677OMIM:144250Hyperlipidemia, familial combined, 3106
HP:0010732HP:0010732Nodular changes affecting the eyelids0PCSK9 CL E G H25573820001OMIM:603776HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3178
HP:0010732HP:0010732Nodular changes affecting the eyelids0PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0010732HP:0010732Nodular changes affecting the eyelids0PPP1R17 CL E G H1084216973OMIM:143890Hypercholesterolemia, familial, 12
HP:0010732HP:0010732Nodular changes affecting the eyelids0PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0010732HP:0010732Nodular changes affecting the eyelids0SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib110
HP:0010732HP:0010732Nodular changes affecting the eyelids0SLC37A4 CL E G H25424061OMIM:232220Glycogen storage disease ib110
HP:0010732HP:0010732Nodular changes affecting the eyelids0SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic110
HP:0010732HP:0010732Nodular changes affecting the eyelids0SPRED1 CL E G H16174220249ORPHA:137605Legius syndrome136
HP:0010732HP:0010732Nodular changes affecting the eyelids0TTPA CL E G H727412404OMIM:277460VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF62
HP:0010732HP:0010606Hordeolum1 CL E G H
HP:0010732HP:0010604Cyst of the eyelid1 CL E G H
HP:0010732HP:0001114Xanthelasma1ABCA1 CL E G H1929ORPHA:425Apolipoprotein A-I deficiency191
HP:0010732HP:0001114Xanthelasma1ABCG8 CL E G H6424113887OMIM:210250Sitosterolemia 176
HP:0010732HP:0001114Xanthelasma1APOA1 CL E G H335600ORPHA:425Apolipoprotein A-I deficiency40
HP:0010732HP:0001114Xanthelasma1APOA2 CL E G H336601OMIM:143890Hypercholesterolemia, familial, 19
HP:0010732HP:0001114Xanthelasma1APOB CL E G H338603OMIM:144010Hypercholesterolemia, familial, 2.356
HP:0010732HP:0001114Xanthelasma1APOE CL E G H348613ORPHA:412DysbetalipoproteinemiaHP:0040282 - Frequent39
HP:0010732HP:0001114Xanthelasma1CYP27A1 CL E G H15932605OMIM:213700Cerebrotendinous xanthomatosis114
HP:0010732HP:0001114Xanthelasma1EPHX2 CL E G H20533402OMIM:143890Hypercholesterolemia, familial, 11
HP:0010732HP:0001114Xanthelasma1G6PC1 CL E G H25384056OMIM:232200Glycogen storage disease ia.
HP:0010732HP:0001114Xanthelasma1GHR CL E G H26904263OMIM:143890Hypercholesterolemia, familial, 198
HP:0010732HP:0001114Xanthelasma1LDLR CL E G H39496547OMIM:143890Hypercholesterolemia, familial, 12157
HP:0010732HP:0001114Xanthelasma1LPL CL E G H40236677OMIM:144250Hyperlipidemia, familial combined, 3HP:0040283 - Occasional106
HP:0010732HP:0001114Xanthelasma1PCSK9 CL E G H25573820001OMIM:603776HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3178
HP:0010732HP:0001114Xanthelasma1PPP1R17 CL E G H1084216973OMIM:143890Hypercholesterolemia, familial, 12
HP:0010732HP:0001114Xanthelasma1SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type IbHP:0040283 - Occasional110
HP:0010732HP:0001114Xanthelasma1SLC37A4 CL E G H25424061OMIM:232220Glycogen storage disease ib.110
HP:0010732HP:0001114Xanthelasma1SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic.110
HP:0010732HP:0001114Xanthelasma1SPRED1 CL E G H16174220249ORPHA:137605Legius syndrome136
HP:0010732HP:0001114Xanthelasma1TTPA CL E G H727412404OMIM:277460VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF.62
HP:0010732HP:0010605Chalazion2 CL E G H
HP:0010732HP:0010608Hordeolum internum2 CL E G H
HP:0010732HP:0010607Hordeolum externum2 CL E G H


Genes (19) :ABCA1 ABCG8 APOA1 APOA2 APOB APOE CYP27A1 EPHX2 G6PC1 GHR LDLR LPL PCSK9 PDE11A PPP1R17 PRKAR1A SLC37A4 SPRED1 TTPA

Diseases (15) :ORPHA:425 OMIM:210250 OMIM:143890 OMIM:144010 ORPHA:412 OMIM:213700 OMIM:232200 OMIM:144250 OMIM:603776 ORPHA:1359 ORPHA:79259 OMIM:232220 OMIM:232240 ORPHA:137605 OMIM:277460
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.